Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation. 2021

Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
Normandie Univ, INSERM Unit 1073, University of Rouen Normandy, Rouen, France.

Intestinal fibrosis is a frequent complication in inflammatory bowel diseases (IBD). It is a challenge to identify environmental factors such as diet that may be driving this risk. Intestinal fibrosis result from accumulation of extracellular matrix (ECM) proteins secreted by myofibroblasts. Factors promoting intestinal fibrosis are unknown, but diet appears to be a critical component in its development. Consumption of salt above nutritional recommendations can exacerbate chronic inflammation. So far, high salt diet (HSD) have not been thoroughly investigated in the context of intestinal fibrosis associated to IBD. In the present study, we analyze the role of dietary salt in TNBS chronic colitis induced in rat, an intestinal fibrosis model, or in human colon fibroblast cells. Here, we have shown that high-salt diet exacerbates undernutrition and promoted ECM-associated proteins in fibroblasts. Taken together, our results suggested that dietary salt can activate intestinal fibroblasts, thereby contributing to exacerbation of intestinal fibrosis. Dietary salt may be considered as a putative environmental factor that drives intestinal fibrosis risk.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D003092 Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. Colitides
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
August 2017, Journal of immunology (Baltimore, Md. : 1950),
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
September 2017, Journal of clinical biochemistry and nutrition,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
January 2017, Oncotarget,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
June 2020, International immunopharmacology,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
November 2022, Journal of Crohn's & colitis,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
December 2008, Gastroenterology,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
November 2020, Scientific reports,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
April 2020, Journal of ethnopharmacology,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
January 2022, Frontiers in pharmacology,
Asma Amamou, and Matthieu Rouland, and Linda Yaker, and Alexis Goichon, and Charlène Guérin, and Moutaz Aziz, and Guillaume Savoye, and Rachel Marion-Letellier
February 2023, Microbiology spectrum,
Copied contents to your clipboard!